Abbott CEO Rules Out Selling $8.5B Nutrition Business: 'No Interest'
Bullish strength: 35/100
- Revenue rose 14.5% year over year, slightly beating market expectations
Bearish strength: 65/100
- This news concerns traditional stock business and has weak relevance to ABTSTOCK crypto assets
- Abbott lowers comparable sales growth forecast to around 6%
This is automated NewsSignals analysis of third-party reporting, not independent original reporting or investment advice. AI scores are not price predictions.